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Abstract
FOXM1, a member of the forkhead box transcription factor family, plays a key role in cell cy-
cling progression by regulating the expression of critical G1/S and G2/M phase transition
genes. In vivo studies reveal that Foxm1 null mice have a 91% lethality rate at e18.5 due to
significant cardiovascular and hepatic hypoplasia. Thus, FOXM1 has emerged as a key pro-
tein regulating mitotic division and cell proliferation necessary for embryogenesis. In the cur-
rent study, we assess the requirement for Foxm1 in the developing pituitary gland. We find
that Foxm1 is expressed in the pituitary at embryonic days 10.5-e18.5 and localizes with
markers for active cell proliferation (BrdU). Interestingly, direct analysis of Foxm1 null mice
at various embryonic ages, reveals no difference in gross pituitary morphology or cell prolif-
eration. We do observe a downward trend in overall pituitary cell number and a small reduc-
tion in pituitary size in e18.5 embryos suggesting there may be subtle changes in pituitary
proliferation not detected with our proliferation makers. Consistent with this, Foxm1 null
mice have reductions in both the somatotrope and gonadotrope cell populations.
Introduction
The development of the anterior pituitary gland involves a highly orchestrated cascade of mor-
phogenetic signals and transcription factors that give rise to five hormone-secreting cell line-
ages in a characteristic spatial and temporal manner. These endocrine cell lineages are of
primary importance in the regulation of critical physiological functions including control of
metabolism, growth, lactation, and reproduction. Despite recent progress defining the tran-
scriptional mechanisms that underlie pituitary organogenesis and cell differentiation, our un-
derstanding of these mechanisms is far from complete. [1, 2].
Forkhead box (FOX) transcription factors are a family of proteins that share a highly con-
served DNA binding domain [3] and control a range of functions in the cell, including
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development [4, 5], cell cycle control [6, 7], cell survival [8–10], metabolism [11, 12], and
immunoregulation [13, 14]. Interestingly, recent work has highlighted the observation that sev-
eral forkhead factors affect both pituitary cell differentiation and function. The impact of fork-
head proteins on pituitary development was made strikingly clear with the initial discovery
that FOXL2 [15] regulates several genes necessary for gonadotrope function, including those
that code for gonadotropin-releasing hormone receptor, Cga, and Fshb [16–20]. Indeed, with-
out FOXL2, FSH production is severely impaired, causing infertility [21]. FOXP3, typically
thought to be involved in the development and regulation of T cells, is not expressed the pitui-
tary gland, but is important for maintaining appropriate gonadotropin levels [22]. A mutation
in Foxp3 results in severely reduced Lhb and Fshb levels, leading to infertility [22–24]. FOXD1,
while also not expressed in the pituitary, appears essential for up regulation of genes necessary
for LH production [25]. In contrast, FOXA1 is part of a complex that represses Gh1 expression
[26]. Similarly, FOXO1 represses Lhb expression in studies using immortalized cell lines [27].
Thus, there is clear evidence that forkhead factors play a critical role in pituitary function.
However, the role of the proliferation-associated forkhead transcription factor, FOXM1, within
the pituitary remains largely undefined.
FOXM1 (Accession No. NM_008021) is a transcription factor that plays an essential role in
organogenesis by controlling expression of genes involved in cell cycle progression and mitotic
division. Given the critical role of cell proliferation in organ development, it is not surprising
that deletion of Foxm1 results in 91% lethality by embryonic day (e)18.5 [28]. The high lethality
can be attributed to significant cardiovascular anomalies including myocardium defects and
ventricular hypoplasia [29]. In addition, hepatoblasts of the liver fail to enter mitosis [28], and
severe abnormalities of pulmonary vasculature are also detected in Foxm1 null animals[30].
Previous work has found that FOXM1 is expressed in the embryonic pituitary [31]. Thus,
we were intrigued with the possibility that FOXM1 plays an important role in cell proliferation
necessary for pituitary development. Here we compare pituitary morphology, hormone pro-
duction and cell proliferation of mouse embryos deficient in Foxm1 with their wild type litter-
mates. We observe no difference in proliferation, but a reduction the number of somatotropes
and gonadotropes is apparent.
Materials and Methods
Mice
Foxm1 knockout mice were graciously provided by Dr. Raychaudhuri, University of Illinois at
Chicago, and maintained on a C57BL/6J background [28]. Mice were kept under a 12-hour
dark-light cycle and fed Purina Mills Formulab diet 5008 ad libitum. The morning the copula-
tory plug was detected was considered to be embryonic day 0.5 (e0.5). Embryos were obtained
from mating of Foxm1+/- mice. Littermates were used for all experiments in which normal and
mutant embryos were compared. Genotyping for the wild type Foxm1 allele was performed
using quantitative polymerase chain reaction (qPCR) with the following primers: 5’-ATGTT
GACACCAGGCCTACCAGAA and 5’-TATGTGTGGAACGCAGGAAGGTGA. To genotype the
null allele, polymerase chain reaction (PCR) was used with the following primers: 5’-TGGCT
TCCCAGCAGTACAAATC and 5’- TCTCGCTCAATTCCAAGACCAG.
The Southern Illinois University Animal Care and Use Committee approved all procedures
using mice (Animal Assurance Number A-3078-01). All experiments were conducted in accord
with the principles and procedures outlined in the NIH Guidelines for the Care and Use of Ex-
perimental Animals.
FOXM1 in Pituitary Development
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Histology and Immunohistochemistry
To detect cell proliferation in embryonic pituitaries, pregnant mice were given an intraperito-
neal injection of bromodeoxyuridine (BrdU) at 100 μg/g body weight 2 hours before the em-
bryos were collected [32]. Pregnant dams were euthanized by CO2 inhalation and embryos
were dissected from the uterus. Embryos were euthanized by submerging in ice cold PBS.
Embryos were fixed in 4% formaldehyde in phosphate buffered saline (PBS; pH 7.2) for 45
minutes to 24 hours (depending on the stage of development). Any embryos that were discol-
ored or underdeveloped as compared to littermates were considered dead and were not includ-
ed in our analyses. All samples were then washed in PBS, dehydrated in a graded series of
ethanol and embedded in paraffin. Five micron sections were deparaffinized in xylene, rehy-
drated through a series of graded ethanol washes. Mid-coronal sections that were comparable
between wild type and mutants were chosen for immunohistochemistry to label the various
hormone-secreting cell types at e17.5 and e18.5. Due to the small size of early stage pituitaries,
mid-sagittal, rather than coronal, sections were chosen for pituitary stages prior to e17.5.
To visualize BrdU, FOXM1 and phosphohistone H3 (pHH3), endogenous peroxidases were
removed with 1.5% hydrogen peroxide in water. Epitopes were then unmasked by boiling in
10mM citric acid for 10 minutes followed by a 20 minute cool down. The specimens were
blocked using the blocking solution from the tyramide signal amplification (TSA) fluorescein
isothiocyanate (FITC) kit (Perkin-Elmer Life Sciences, Boston, MA) for 10 minutes then incu-
bated with primary antibodies for BrdU (Invitrogen, Boston, MA, mouse, 1:100), FOXM1
(Santa Cruz Biotechnology, Santa Cruz, CA, rabbit, 1:30) or pHH3 (Millipore, Temecula, CA,
rabbit, 1:100) overnight at 4°C (Table 1). BrdU specimens were then incubated with the appro-
priate anti-mouse biotinylated secondary antibodies (Vector, Burlingame, CA, goat, 1:200) for
30 minutes while FOXM1 and pHH3 specimens were incubated with bioinylated anti-rabbit
antibodies (Jackson, West Grove, PA, goat, 1:200). All specimens were incubated in streptavi-
din-horseradish peroxidase (Perkin-Elmer) for 30 minutes, followed by a 10 minute incubation
in FITC (Perkin-Elmer). The sections were finally incubated for 5 minutes with 4’,6-diami-
dino-2-phenylindole (DAPI) (1:100; 167 nM, Molecular Probes, www.invitrogen.com) and
mounted using Aquamount (Lerner Laboratories, Pittsburgh, PA).
Table 1. Antibody Information.
Name Clonality Host Supplier Cat. No. Immunogen Registry ID
FOXM1 polyclonal rabbit Santa Cruz sc-502 C-terminus of human FOXM1 AB_631523
BrdU monoclonal mouse Life Technologies B35128 5-iodouridine AB_10562901
p57 polyclonal rabbit Santa Cruz sc-8298 aa 45–135 of human p57 AB_2078155
pHH3 polyclonal rabbit Millipore 06–570 human pHH3 (Ser10) AB_310177
pERK monoclonal rabbit Cell Signaling 4370 Thr202/Tyr204 of human p44 MAP kinase AB_2315112
ACTH polyclonal rabbit NHPP N/A rat ACTH AB_2313902
TSHB polyclonal rabbit NHPP N/A rat TSHB N/A
GH polyclonal rabbit NHPP N/A mouse GH N/A
CGA polyclonal rabbit NHPP N/A rat CGA N/A
LHB polyclonal guinea pig NHPP N/A rat LHB N/A
biotin anti-mouse polyclonal goat Vector Laboratories BA-9200 mouse AB_2336171
biotin anti-rabbit polyclonal goat Jackson Laboratories 111-067-003 rabbit AB_2337971
alexa ﬂuor 488 anti-rabbit polyclonal goat Molecular Probes A-11008 rabbit AB_143165
TRITC-anti-guinea pig polyclonal donkey Jackson Laboratories 706-026-148 guinea pig AB_2340446
TRITC-anti-rabbit polyclonal goat Jackson Laboratories 111-297-003 rabbit AB_2338034
doi:10.1371/journal.pone.0128942.t001
FOXM1 in Pituitary Development
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Double immunohistochemistry for FOXM1 with BrdU or pHH3, was performed by detect-
ing FOXM1 as described above. Tissue sections were then blocked for 15 minute with strepta-
vidin and biotin block (Vector Laboratories, 1:50) as well as with anti-rabbit Fab fragment
according to manufacturer’s instructions and BrdU or pHH3 was detected as described above,
except that sections were incubated with TRITC (Perkin-Elmer) rather than FITC. Controls in
which each primary antibody was omitted were performed and revealed minimal cross-reactiv-
ity between stains (data not shown).
For immunofluorescent labeling of p-ERK1/2, pituitary sections were fixed, embedded, and
epitopes unmasked as described above. Sections were washed in TBS and blocked with 10%
normal goat serum/2x casein in TBS for 30 min at room temperature. Sections were then incu-
bated in anti-p-ERK1/2 primary antibody diluted 1:80 in TBS/1× casein overnight; additionally
normal rabbit IgG at equivalent concentration (micrograms/ml) was used as negative control.
After overnight primary antibody incubation, sections were washed with TBS and incubated
with Alexa Fluor 488 anti-rabbit secondary antibody (1:100) for 20 min at room temperature
in the dark. Slides were then washed and mounted in Vectashield with DAPI. Images were ob-
tained on a Zeiss 710 Laser Scanning Confocal Microscope using the appropriate filters.
To visualize adrenocorticotropic hormone (ACTH), thyroid stimulating hormone (TSHB),
growth hormone (GH), the common α-subunit (CGA) and luteinizing hormone (LHB), tissue
sections were blocked with TSA blocking solution (Perkin-Elmer Life Sciences) and incubated
with the appropriate antibody (National Hormone and Peptide Program, Torrance, CA) for
one hour at room temperature. Tissue sections were incubated with anti-guinea pig or anti-
rabbit secondary antibodies that are directly conjugated to TRITC (Jackson Immunoresearch
West Grove, PA, 1:100) for 30 minutes to detect LHB or ACTH, GH, TSHB and CGA, respec-
tively. Sections were stained with DAPI and mounted as above.
Pituitary morphology was observed by staining tissue sections with hematoxylin and eosin.
Briefly, paraffin was melted and then removed with two washes of citraclear. The sections were
then washed in three changes of 100% ethanol for two minutes each, wash in distilled water for
two minutes, incubated in filtered hematoxylin for 4 minutes then washed in distilled water.
Sections were dipped in acid alcohol and then lithium carbonate followed by a rinse in distilled
water and then dipped in eosin 1–5 times. Sections were placed in 100% isopropyl alcohol
three times for 2 minutes each before mounting.
Digital images were captured with a Leica DM 5000B fluorescent microscope and Retiga
2000R digital camera. DAPI and the corresponding FITC and/or TRITC pictures were merged
using Adobe Photoshop CS3.
Histological Quantification
Phosphohistone H3-positive cells were separated into dimly fluorescent cells, which mark cells
in late G2 phase, and brightly stained cells, which mark cells in M phase [33]. The total number
of pituitary cells was counted by labeling cell nuclei with DAPI. A ratio of cells in late G2 or in
M phase to total DAPI count was calculated for each pituitary. Four to five littermate pairs
were analyzed and one section was counted per pituitary.
The total number of BrdU-positive and DAPI-positive cells per tissue section were counted
at ages e10.5, e12.5 and e14.5. The entire pituitary could be viewed at 200x magnification at all
ages. A ratio of positive cells to total DAPI count was calculated for each pituitary. Four to five
littermate pairs were analyzed and one section was counted per pituitary.
LHB, GH, TSHB, CGA and ACTH-positive cells and DAPI-positive cells were counted
manually at e17.5 and e18.5. The entire pituitary could not be viewed at 200x magnification, so
only half of the pituitary was counted. Only the intermediate and anterior lobes were counted.
FOXM1 in Pituitary Development
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A ratio of positive cells to total DAPI count was calculated for each pituitary. The ratios were
then standardized to the wild type littermate. Four to seven littermate pairs were analyzed and
one section was counted per pituitary.
Area was determined for approximately three sections per pituitary using ImageJ64. The an-
terior pituitary was outlined in ImageJ64 and area was measured in μm2. Values were set rela-
tive to wild type controls for each littermate pair. Four littermate pairs were analyzed for the
e12.5 age group and eight littermate pairs were analyzed for the e14.5 and e18.5 age groups.
Quantitative RT-PCR
Pituitary glands were dissected from e17.5 and e18.5 embryos. RNA was then isolated using
the RNAqueous-Mcro kit (Ambion, Inc.) according to manufacturer’s instructions. RNA was
treated with DNase I and DNase inactivating reagent from the TURBO DNase-free kit
(Ambion, Inc.) as per manufacturer’s instructions. RNA concentrations were determined by
spectrophotometry at 260nm. Ten ng of total RNA was used with the TaqMan RNA-to-CT
1-step Kit and TaqMan probes. Amplification was accomplished using Taqman Gene Expres-
sion Assays (Applied Biosystems) as per manufacturer’s instructions: Cga (Accession No.
NM_009889)(Mm01209400_m1), Gh1 (Accession No. NM_008117)(Mm00433590_g1), Pomc
(NM_001278581)(Mm00435874_m1), Lhb (Accession No. NM_008497)(Mm00656868_g1)
and Tshb (Accession No. (Accession No. BC144732)(Mm00437190_m1), utilizing Actb (Ac-
cession No. NM_007393)(4352933E) as the endogenous control (all Taqman probes from Ap-
plied Biosystems, Inc.). All experiments were performed in triplicate. Real time RT-PCR was
performed on a CFX96 Real Time System (BioRad). Experiments were run at 48°C for 15 min-
utes to synthesize the cDNA followed by 10 minutes at 95°C to deactivate the reverse transcrip-
tase and activate the Taq polymerase and then 40 cycles of 95°C for 15 seconds and 60°C for 1
minute for amplification. No-template controls and no-reverse transcriptase controls were
used to assure the absence of contamination and efficacy of the DNase treatment, respectively.
Melt curve analysis was performed to ensure that no primer-dimer amplification occurred.
Data were analyzed by the ΔΔCT method [34, 35]. The values for ΔΔCT were calculated by sub-
tracting the average ΔCT of wild type controls from the ΔCT for each sample. CT values over 30
were considered unreliable and were not included in our analyses.
Statistical Analysis
All results are expressed as mean ± SEM. Data were analyzed by Student’s t-test using Micro-
soft Excel. P-values less than 0.05 were considered significant ().
Results
FOXM1 Expression During Pituitary Development
To begin identifying the role that FOXM1 plays in anterior pituitary organogenesis, we first
examined the spatial and temporal distribution of FOXM1 in the normal mouse pituitary
over the course of embryonic development and in adulthood using immunohistochemistry.
While FOXM1 was present at all ages examined, the proportion of FOXM1 immuno-positive
nuclei dropped as development progressed. At early embryonic ages (Fig 1A and 1B), a large
percentage of the cells in the nascent pituitary contain the FOXM1 protein, consistent with
high levels of cell proliferation at these stages of development. With the beginning of termi-
nal differentiation in the pituitary, a reduction in FOXM1 positive cells was seen at e14.5 (Fig
1C–1F) [1, 36, 37]. To directly test whether FOXM1 localizes to proliferating cells, we per-
formed double immunohistochemistry on wild type mice at e16.5, for FOXM1 and BrdU
FOXM1 in Pituitary Development
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(Fig 2A–2C). We found that within the pituitary, FOXM1 consistently co-localizes with
BrdU. Non-cycling precursors were marked by labeling p57 [38]. We found that FOXM1 is
not present in cells that have left the cell cycle, consistent with its role as a promoter of cell
cycle progression (Fig 2D–2F).
Pituitary Morphology and Cell Proliferation in Foxm1-Deficient Embryos
Our data support the conclusion that FOXM1 is present in actively dividing pituitary cells dur-
ing early stages of development, thus we hypothesized that deletion of Foxm1 would lead to sig-
nificant malformation of Rathke’s pouch. If correct, we would expect changes in gross pituitary
Fig 1. The number of FOXM1-positive cells decreases as pituitary development progresses.
Immunohistochemistry for FOXM1 was performed to identify its expression pattern in murine pituitary gland
at (A) embryonic day 10.5 (e10.5), (B) e12.5, (C) e14.5, (D) e16.5 and (E) e18.5 as well as in (F) adult
pituitary. All specimens are midsagittal sections (A-D), except for e18.5 and adult sections (E, F), which are
oriented coronally. FOXM1 is most abundant in the early stages of development (A, B), when cell proliferation
is greatest. As proliferation slows and differentiation begins at e16.5 and e18.5 (D,E), the number of FOXM1
positive cells is reduced. The number is even further reduced in the mature pituitary (F), as the differentiated
cells have left the cell cycle. Scale bar represents 100 μm.
doi:10.1371/journal.pone.0128942.g001
FOXM1 in Pituitary Development
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morphology. To test this notion, we compared wild type embryos stained with hematoxylin
and eosin with their Foxm1 null littermates (Fig 3). Surprisingly, morphological analysis did
not reveal any overt changes in overall pituitary structure.
Despite no change in morphology, at issue is the level of cell proliferation within pituitary
from Foxm1 null embryos. To directly test this, proliferation of Foxm1 null embryos and their
wild type littermates was compared using pHH3. Not only is pHH3 a proliferation marker, it
can also be used to differentiate between cells in late G2 phase and M phase. G2 cells have sig-
nificantly fewer histones phosphorylated and so stain more dimly than cell in M phase, which
are brightly stained due to the increased phosphorylated H3 subunits [33]. When Foxm1 null
embryos were compared to their wild type littermates, there was no statistical difference in the
number of G2 phase cells, M phase cells or total pHH3 positive cells at e10.5, e12.5 or e14.5
(Fig 4A–4L). Extracelluar signal regulated kinase (ERK), promotes proliferation in many tis-
sues and its activity is sustained by FOXM1 in hepatocellular carcinoma cells [39, 40]. Consis-
tent with no changes in pituitary cell proliferation, we also observed no difference in activity of
ERK in Foxm1 null embryos at e10.5 (data not shown).
As an alternative proliferation marker, BrdU was also analyzed. Again, no significant differ-
ence in the number of BrdU-positive cells in the pituitary gland was observed between Foxm1
null embryos and wild type littermates at e10.5, e12.5 or e14.5 (Fig 5A–5I). In agreement with
the literature, the percent of cells staining for BrdU in the pituitary fell with increasing age
(data not shown). Additionally, pituitary sections from wild type and Foxm1 null embryos
were labeled with the proliferation marker, Ki67. No significant difference in the number of
Ki67-immunopositive cells was observed between genotypes (data not shown).
Our data suggests there are no changes in anterior pituitary cell proliferation and morpholo-
gy in Foxm1 null embryos, therefore we next sought to confirm our results by quantitatively
analyzing the pituitary cell density. Pituitary sections were labeled with DAPI and stained cells
Fig 2. FOXM1 is present in actively proliferating cells. FOXM1 (green) and a marker for cells in S phase, BrdU (red), were labeled in midsagittal pituitary
sections from wild type e16.5 mouse embryos (A-C). FOXM1 (green) and a marker for non-cycling precursors, p57 (red), were labeled in midsagittal pituitary
sections from wild type e14.5 mouse embryos (D-F). Scale bar represents 100 μm.
doi:10.1371/journal.pone.0128942.g002
FOXM1 in Pituitary Development
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Fig 3. Foxm1-/- pituitary glands exhibit normal morphology. Pituitary glands of Foxm1-/- embryos (KO)
and wild type littermates (WT) were stained with hematoxylin and eosin at (A-B) embryonic day 10.5 (e10.5),
(C-D) e12.5, (E-F) e14.5 and (G-H) e18.5. No gross morphological differences were seen between the pairs.
Scale bar represents 100 μm.
doi:10.1371/journal.pone.0128942.g003
FOXM1 in Pituitary Development
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were quantitated. We observed no significant difference between the number of cells per pitui-
tary section between Foxm1 null embryos and their wild type littermates at e10.5, e12.5, e14.5
and e18.5, although there was a trend toward decreased cell number in Foxm1 null pituitary
glands at later ages (Fig 5J).
Fig 4. No significant difference in M phase or G2 phase is apparent in Foxm1-/- pituitary glands. Immunohistochemistry was performed on midsagittal
pituitaries from Foxm1-/- embryos (KO) and wild type littermates (WT) at embryonic day 10.5 (e10.5), e12.5, and e14.5 embryos to identify cellular
proliferation. (A-F) Staining of phosphohistone H3 (pHH3, green) allows for differentiation between cells in M phase (brightly stained, white arrow) and G2
phase (dimly stained; red arrow). Cells in M phase, G2 phase and total cells per pituitary section were counted for each age and genotype. Graphs represent
the ratio of cells in (G-I) M phase or (J-L) G2 phase to total DAPI (blue) counts per pituitary section. Data are expressed as mean ± SEM of four or five
littermate pairs for each age. The data were analyzed by Student t-test to determine significant difference betweenWT and KO.
doi:10.1371/journal.pone.0128942.g004
FOXM1 in Pituitary Development
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Fig 5. No significant difference in S phase is apparent in Foxm1-/- pituitary glands. (A-F) BrdU (red) was used as a marker for cells in S phase and DAPI
(blue) labels all cell nuclei. Scale bar represents 100 μm. (G-I) A ratio of BrdU-positive cells to total DAPI count per pituitary section was calculated for Foxm1-/-
embryos (KO) and wild type littermates (WT) at each age. Data are expressed as mean ± SEM of four or five littermate pairs for each age. The data were
analyzed by Student t-test to determine significant difference betweenWT and KO. (J) The total number of cells per pituitary section was counted for
embryonic day 10.5 (e10.5), e12.5, e14.5, e18.5 in Foxm1-/- (KO) and wild type littermates (WT). Data are expressed as mean ± SEM of six littermate pairs for
each age. The data were analyzed by Student t-test to determine significant difference betweenWT and KO. (K) Area of approximately three pituitary sections
per individual was measured. Values are shown relative to WT littermate controls. Data are expressed as mean ± SEM of four littermate pairs for e12.5 and
eight littermate pairs for e14.5 and e18.5. The data were analyzed by Student t-test to determine significant difference betweenWT and KO (*P<0.05).
doi:10.1371/journal.pone.0128942.g005
FOXM1 in Pituitary Development
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To more carefully analyze pituitary size, the area of pituitary tissue sections was measured at
e12.5, e14.5 and e18.5 (Fig 5K). Foxm1 null embryos were not significantly smaller at e12.5 or
e14.5, although there was a downward trend in area of pituitary sections at e14.5. At e18.5
there was a small but significantly decrease in area of pituitary sections in Foxm1 null embryos
as compared to wild type littermate controls, suggesting that Foxm1 is required for normal
growth of the embryonic pituitary gland.
Hormone Production in Foxm1-Deficient Embryos
To determine if Foxm1 is required for normal pituitary cell lineage commitments, immunohis-
tochemistry was performed on e17.5-e18.5 embryos deficient in Foxm1 or their wild type litter-
mates for markers of the 5 endocrine cell types. Individual cell types from Foxm1 null embryos
and wild type littermates were counted and expressed as a ratio of the total number of pituitary
cells (Fig 6A–6O). Interestingly, the number of GH-, CGA- and LHB-positive cells was signifi-
cantly reduced in Foxm1 null embryos, suggesting that Foxm1 is required for normal numbers
of somatotropes and gonadotropes to differentiate. No significant difference was observed in
the number of ACTH- or TSHB-positive cells.
To more accurately quantify hormone expression in Foxm1 null embryos, we employed
quantitative reverse transcription polymerase chain reaction (qRT-PCR). Consistent with a re-
duced number of somatotropes, expression of the gene encoding for GH (Gh1) was modestly
but significantly reduced in Foxm1 null embryos as compared to wild type littermates (Fig 7).
While expression of Lhb and Cga showed a trend toward being reduced in Foxm1 null embry-
os, this was not statistically significant. While not statistically significant, an upward trend was
observed in expression of Pomc or Tshb. We did not assess prolactin or follicle-stimulating hor-
mone mRNA levels because they are present in such low quantities in the embryo it is very dif-
ficult to measure reliably [41].
Discussion
Previous work has highlighted the essential role of FOXM1 in cell cycle progression in various
tissues [28, 42] although its role in pituitary organogenesis remains unknown. We find that
FOXM1 is present in actively proliferating pituitary cells during development consistent with a
role in promoting proliferation during pituitary development (Fig 1). Interestingly, when we
assessed the number of proliferating cells in in the pituitary glands of Foxm1 null embryos, we
saw no statistical difference in proliferation at any age analyzed (Figs 4 and 5). However, we
did observe a downward trend in the number of cells at e18.5 (Fig 5J). Additionally, the area of
Foxm1-/- pituitaries is significantly reduced at e18.5 (Fig 5K). These data, together with the fact
that we observe a decrease in the number of somatotropes and gonadotropes, (Figs 6 and 7)
suggest there may be a subtle defect in pituitary cell proliferation in Foxm1 null embryos that is
not statistically significant. If correct, it would suggest a differential requirement of FOXM1 for
proliferation among precursors for the various pituitary hormone-producing cells. This is not
without precedent; in pulmonary tissues. Kim, et al. [30] observed a reduction in proliferation
of the embryonic Foxm1 null lung mesenchyme, however proliferation was normal in Foxm1
null epithelial cells.
During anterior pituitary development, corticotropes arise first, followed by thyrotropes.
Somatotropes, gonadotropes and lactotropes terminally differentiate later [43]. We did not as-
sess lactotrope differentiation because prolactin is present in such low levels in the embryo it is
very difficult to measure reliably [41]. The fact that corticotropes and thyrotropes exhibit an
upward trend, although statistically insignificant, while somatotropes and gonadotropes are re-
duced in the absence of Foxm1 null mice suggests a temporal requirement for FOXM1 during
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Fig 6. The number of cells containing GH, LHB, and CGA are reduced in Foxm1-/- pituitary glands. Immunohistochemistry for (A-B) GH (red), (D-E)
CGA (red), (G-H) ACTH (red), (J-K) LHB (red), (M-N) TSHB (red) was performed on e17.5/18.5 coronal sections. DAPI (blue) labels all cell nuclei. Scale bar
represents 100 μm. The total number of cells containing (C) GH, (F) CGA, (I) ACTH, (L) LHB, (O) TSHB and total DAPI in each pituitary were counted for
Foxm1-/- embryos (KO) and wild type (WT) littermates. The KO ratio (hormone/DAPI) was then normalized to theWT ratio. Data are expressed as mean ± SEM
of 4–6 littermate pairs for each age. The data were analyzed by Student t-test to determine significant difference betweenWT and KO (*P < 0.05).
doi:10.1371/journal.pone.0128942.g006
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pituitary development, and a possible shift in the pituitary cell population toward the cells that
differentiate early in pituitary ontogeny, namely the corticotropes and thyrotropes and away
from cells that differentiate later, somatotropes and gonadotropes. It is unlikely that these
small changes in hormone expression would affect embryonic development or growth and fer-
tility of these mice had they been able to live to adulthood.
Lineage commitment and differentiation of cells occur in a sequential manner and are or-
chestrated by combinatorial expression of cell type-specific transcription factors and epigenetic
modifications. Thus, it is possible that FOXM1 contributes to differentiation of hormone-se-
creting cell types in the developing pituitary gland rather than or in addition to their prolifera-
tion. Towards this end, recent work has highlighted that FOXM1 facilitates the differentiation
of bronchiolar epithelial cells in mice and primary neuronal differentiation in Xenopus [44].
The reduction in somatotropes and gonadotropes that we observe in Foxm1-/- embryos could
be due to misregulation of transcription networks that are involved in the differentiation of
these cell types in the absence of FOXM1. It is known that Foxm1 is required for β-catenin acti-
vation and the expression of Wnt target genes [45]. β-catenin has recently been shown to play
a critical role in a multicomponent transcriptional network required for regulated expression
of Cga and Lhb in the gonadotrope [46]. In somatotropes, β-catenin is important in maintain-
ing homotypic cell to cell contacts. Reduction of β-catenin correlates with disruption in the or-
ganization of the somatotrope cell network [47]. The inability of somatotropes to effectively
communicate with one another and initiate coordinated and appropriate signal transduction
could contribute to reduced GH expression seen in our model.
We conclude that FOXM1 is required for normal somatotrope and gonadotrope numbers
and for normal pituitary size. The reduction in cell numbers and pituitary size may be due to
effects on proliferation of pituitary precursor cells that are too subtle to be detected using our
current methodology. Alternatively, the reduction in the number of somatotrope and gonado-
trope cells could indicate a role for FOXM1 in differentiation of these cell types. The effects of
FOXM1 on pituitary cell number and/or differentiation may be partially compensated for by
Fig 7. Expression ofGh1 is reduced in Foxm1-/- pituitary glands.Real time RT-PCR for the genes
encoding growth hormone (Gh1), luteinizing hormone β (Lhb), the common α subunit (Cga), the precursor for
ACTH (Pomc) and thyroid stimulating hormone (Tshb) was performed on RNA isolated from pituitary of e17.5
and e18.5 Foxm1-/- embryos (KO) and wild type littermates (WT). Values were calculated using the ΔΔCT
method and normalized to WT. Data are expressed as mean ± SEM of 7 littermate pairs for each age and
were analyzed by Student t-test to determine significant difference betweenWT and KO (*P < 0.05).
doi:10.1371/journal.pone.0128942.g007
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other factors and is a focus of our ongoing work. Identification of these factors in the future
will help elucidate the comprehensive role of FOXM1 in pituitary development.
Acknowledgments
We thank Pradip Raychaudhuri, University of Illinois Chicago, for providing us with Foxm1
heterozygous null mice originally developed by the late Robert Costa. We thank A.F. Parlow
and the National Hormone and Pituitary Program, the National Institute of Diabetes and Di-
gestive and Kidney Diseases, and the National Institute of Child Health and Human Develop-
ment for providing antibodies for TSHB, GH, LHB, ACTH and CGA. We thank Maureen
Doran for her guidance in our histological studies.
Author Contributions
Conceived and designed the experiments: MJC AGP BB DOJ AMN BSE. Performed the experi-
ments: MJC AGP BB DOJ AMN BSE. Analyzed the data: MJC AGP BB DOJ AMN BSE. Con-
tributed reagents/materials/analysis tools: AMN BSE. Wrote the paper: MJC AGP BB DOJ
AMN BSE.
References
1. Davis SW, Castinetti F, Carvalho LR, Ellsworth BS, Potok MA, Lyons RH, et al. Molecular mechanisms
of pituitary organogenesis: In search of novel regulatory genes. Mol Cell Endocrinol. 2010; 323(1):4–
19. Epub 2009/12/23. S0303-7207(09)00620-0 [pii] doi: 10.1016/j.mce.2009.12.012 PMID: 20025935.
2. Cheung CC, Lustig RH. Pituitary development and physiology. Pituitary. 2007; 10(4):335–50. Epub
2007/07/20. doi: 10.1007/s11102-007-0051-9 PMID: 17638086.
3. Wijchers PJ, Burbach JP, Smidt MP. In control of biology: of mice, men and Foxes. Biochem J. 2006;
397(2):233–46. PMID: 16792526.
4. Nishimura DY, Searby CC, Alward WL, Walton D, Craig JE, Mackey DA, et al. A spectrum of FOXC1
mutations suggests gene dosage as a mechanism for developmental defects of the anterior chamber
of the eye. Am J HumGenet. 2001; 68(2):364–72. PMID: 11170889.
5. Mirzayans F, Gould DB, Heon E, Billingsley GD, Cheung JC, Mears AJ, et al. Axenfeld-Rieger syn-
drome resulting frommutation of the FKHL7 gene on chromosome 6p25. Eur J HumGenet. 2000; 8
(1):71–4. Epub 2000/03/14. doi: 10.1038/sj.ejhg.5200354 PMID: 10713890.
6. Medema RH, Kops GJ, Bos JL, Burgering BM. AFX-like Forkhead transcription factors mediate cell-
cycle regulation by Ras and PKB through p27kip1. Nature. 2000; 404(6779):782–7. PMID: 10783894.
7. Martinez-Gac L, Marques M, Garcia Z, Campanero MR, Carrera AC. Control of cyclin G2 mRNA ex-
pression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide
3-kinase and forkhead. Mol Cell Biol. 2004; 24(5):2181–9. Epub 2004/02/18. PMID: 14966295.
8. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, et al. Akt Promotes Cell Survival by Phosphory-
lating and Inhibiting a Forkhead Transcription Factor. Cell. 1999; 96(6):857–68. PMID: 10102273
9. Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers WR. Forkhead transcription
factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol. 2000;
20(23):8969–82. Epub 2000/11/14. PMID: 11073996.
10. Kops GJ, Medema RH, Glassford J, Essers MA, Dijkers PF, Coffer PJ, et al. Control of cell cycle exit
and entry by protein kinase B-regulated forkhead transcription factors. Mol Cell Biol. 2002; 22(7):2025–
36. Epub 2002/03/09. PMID: 11884591.
11. Shih DQ, Navas MA, Kuwajima S, Duncan SA, Stoffel M. Impaired glucose homeostasis and neonatal
mortality in hepatocyte nuclear factor 3alpha-deficient mice. Proc Natl Acad Sci U S A. 1999; 96
(18):10152–7. Epub 1999/09/01. PMID: 10468578.
12. ShenW, Scearce LM, Brestelli JE, Sund NJ, Kaestner KH. Foxa3 (hepatocyte nuclear factor 3gamma)
is required for the regulation of hepatic GLUT2 expression and the maintenance of glucose homeosta-
sis during a prolonged fast. J Biol Chem. 2001; 276(46):42812–7. Epub 2001/09/08. doi: 10.1074/jbc.
M106344200 M106344200 [pii]. PMID: 11546810.
13. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor
Foxp3. Science. 2003; 299(5609):1057–61. Epub 2003/01/11. doi: 10.1126/science.1079490 1079490
[pii]. PMID: 12522256.
FOXM1 in Pituitary Development
PLOS ONE | DOI:10.1371/journal.pone.0128942 June 15, 2015 14 / 16
14. Nehls M, Pfeifer D, Schorpp M, Hedrich H, Boehm T. Newmember of the winged-helix protein family
disrupted in mouse and rat nude mutations. Nature. 1994; 372(6501):103–7. Epub 1994/11/03. doi: 10.
1038/372103a0 PMID: 7969402.
15. Treier M, Gleiberman AS, O'Connell SM, Szeto DP, McMahon JA, McMahon AP, et al. Multistep signal-
ing requirements for pituitary organogenesis in vivo. Genes Dev. 1998; 12(11):1691–704. PMID:
9620855.
16. Ellsworth BS, Egashira N, Haller JL, Butts DL, Cocquet J, Clay CM, et al. FOXL2 in the pituitary: molec-
ular, genetic, and developmental analysis. Mol Endocrinol. 2006; 20(11):2796–805. PMID: 16840539.
17. Ellsworth BS, Burns AT, Escudero KW, Duval DL, Nelson SE, Clay CM. The gonadotropin releasing
hormone (GnRH) receptor activating sequence (GRAS) is a composite regulatory element that inter-
acts with multiple classes of transcription factors including Smads, AP-1 and a forkhead DNA binding
protein. Molecular and Cellular Endocrinology. 2003; 206:93–111. PMID: 12943993
18. Coss D, Mellon PL, Thackray VG. A FoxL in the Smad house: activin regulation of FSH. Trends Endo-
crinol Metab. 2010; 21(9):562–8. Epub 2010/07/06. S1043-2760(10)00094-9 [pii] doi: 10.1016/j.tem.
2010.05.006 PMID: 20598900.
19. Lamba P, Fortin J, Tran S, Wang Y, Bernard DJ. A novel role for the forkhead transcription factor
FOXL2 in activin A-regulated follicle-stimulating hormone beta subunit transcription. Mol Endocrinol.
2009; 23(7):1001–13. Epub 2009/03/28. me.2008-0324 [pii] doi: 10.1210/me.2008-0324 PMID:
19324968.
20. Justice NJ, Blount AL, Pelosi E, Schlessinger D, Vale W, Bilezikjian LM. Impaired FSH{beta} Expres-
sion in the Pituitaries of Foxl2 Mutant Animals. Mol Endocrinol. 2011; 25(8):1404–15. Epub 2011/06/
28. me.2011-0093 [pii] doi: 10.1210/me.2011-0093 PMID: 21700720.
21. Tran S, Zhou X, Lafleur C, Calderon MJ, Ellsworth BS, Kimmins S, et al. Impaired fertility and FSH syn-
thesis in gonadotrope-specific Foxl2 knockout mice. Mol Endocrinol. 2013; 27(3):407–21. Epub 2013/
01/24. me.2012-1286 [pii] doi: 10.1210/me.2012-1286 PMID: 23340250.
22. Jung DO, Jasurda JS, Egashira N, Ellsworth BS. The Forkhead Transcription Factor, FOXP3, Is Re-
quired for Normal Pituitary Gonadotropin Expression in Mice. Biol Reprod. 2012; 86(5):144. Epub
2012/02/24. biolreprod.111.094904 [pii] doi: 10.1095/biolreprod.111.094904 PMID: 22357547.
23. Godfrey VL, Wilkinson JE, Rinchik EM, Russell LB. Fatal lymphoreticular disease in the scurfy (sf)
mouse requires T cells that mature in a sf thymic environment: potential model for thymic education.
Proc Natl Acad Sci U S A. 1991; 88(13):5528–32. PMID: 2062835.
24. Lyon MF. Hypogonadism in scurfy (sf) males. Mouse News Letter. 1986; 74:93.
25. Gumbel JH, Patterson EM, Owusu SA, Kabat BE, Jung DO, Simmons J, et al. The forkhead transcrip-
tion factor, Foxd1, is necessary for pituitary luteinizing hormone expression in mice. PLoS One. 2012; 7
(12):e52156. Epub 2013/01/04. doi: 10.1371/journal.pone.0052156 PONE-D-12-12923 [pii]. PMID:
23284914.
26. Norquay LD, Yang X, Jin Y, Detillieux KA, Cattini PA. Hepatocyte nuclear factor-3alpha binding at P se-
quences of the human growth hormone locus is associated with pituitary repressor function. Mol Endo-
crinol. 2006; 20(3):598–607. PMID: 16239259.
27. Arriola DJ, Mayo SL, Skarra DV, Benson CA, Thackray VG. FOXO1 inhibits transcription of luteinizing
hormone beta in pituitary gonadotrope cells. J Biol Chem. 2012; 287:33424–35. Epub 2012/08/07.
M112.362103 [pii] doi: 10.1074/jbc.M112.362103 PMID: 22865884.
28. Krupczak-Hollis K, Wang X, Kalinichenko VV, Gusarova GA, Wang IC, Dennewitz MB, et al. The
mouse Forkhead Box m1 transcription factor is essential for hepatoblast mitosis and development of
intrahepatic bile ducts and vessels during liver morphogenesis. Dev Biol. 2004; 276(1):74–88. Epub
2004/11/09. S0012-1606(04)00576-7 [pii] doi: 10.1016/j.ydbio.2004.08.022 PMID: 15531365.
29. Ramakrishna S, Kim IM, Petrovic V, Malin D, Wang IC, Kalin TV, et al. Myocardium defects and ventric-
ular hypoplasia in mice homozygous null for the Forkhead Box M1 transcription factor. Dev Dyn. 2007;
236(4):1000–13. Epub 2007/03/17. doi: 10.1002/dvdy.21113 PMID: 17366632.
30. Kim IM, Ramakrishna S, Gusarova GA, Yoder HM, Costa RH, Kalinichenko VV. The forkhead box m1
transcription factor is essential for embryonic development of pulmonary vasculature. J Biol Chem.
2005; 280(23):22278–86. Epub 2005/04/09. M500936200 [pii] doi: 10.1074/jbc.M500936200 PMID:
15817462.
31. Carninci P, Waki K, Shiraki T, Konno H, Shibata K, Itoh M, et al. Targeting a complex transcriptome: the
construction of the mouse full-length cDNA encyclopedia. Genome Res. 2003; 13(6B):1273–89. PMID:
12819125.
32. Nowakowski RS, Lewin SB, Miller MW. Bromodeoxyuridine immunohistochemical determination of the
lengths of the cell cycle and the DNA-synthetic phase for an anatomically defined population. J Neuro-
cytol. 1989; 18(3):311–8. PMID: 2746304.
FOXM1 in Pituitary Development
PLOS ONE | DOI:10.1371/journal.pone.0128942 June 15, 2015 15 / 16
33. Prigent C, Dimitrov S. Phosphorylation of serine 10 in histone H3, what for? J Cell Sci. 2003; 116(Pt
18):3677–85. Epub 2003/08/15. doi: 10.1242/jcs.00735 116/18/3677 [pii]. PMID: 12917355.
34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR
and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25(4):402–8. Epub 2002/02/16. doi: 10.1006/
meth.2001.1262 S1046-2023(01)91262-9 [pii]. PMID: 11846609.
35. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc.
2008; 3(6):1101–8. Epub 2008/06/13. PMID: 18546601.
36. Zhu X, Gleiberman AS, Rosenfeld MG. Molecular physiology of pituitary development: signaling and
transcriptional networks. Physiol Rev. 2007; 87(3):933–63. Epub 2007/07/07. 87/3/933 [pii] doi: 10.
1152/physrev.00006.2006 PMID: 17615393.
37. Koo C-Y, Muir KW, Lam EW. FOXM1: from cancer initiation to progression and treatment. Biochim Bio-
phys Acta. 2012; 1819:28–37. doi: 10.1016/j.bbagrm.2011.09.004 PMID: 21978825
38. Bilodeau S, Roussel-Gervais A, Drouin J. Distinct Developmental Roles of Cell Cycle Inhibitors
P57kip1 and P27kip2 Distinguish Pituitary Progenitor Cell Cycle Exit from Cell Cycle Re-Entry of Differ-
entiated Cells. Mol Cell Biol. 2009. Epub 2009/01/14. MCB.01885-08 [pii] doi: 10.1128/MCB.01885-08
PMID: 19139274.
39. Calvisi DF, Pinna F, Ladu S, Pellegrino R, Simile MM, Frau M, et al. Forkhead box M1B is a determinant
of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. Gut. 2009; 58
(5):679–87. doi: 10.1136/gut.2008.152652 PMID: 19136513
40. ZhangW, Liu HT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell
research. 2002; 12(1):9–18. Epub 2002/04/11. doi: 10.1038/sj.cr.7290105 PMID: 11942415.
41. Brannick KE, Craig ZR, Himes AD, Peretz JR, WangW, Flaws JA, et al. Prenatal exposure to low
doses of bisphenol a increases pituitary proliferation and gonadotroph number in female mice offspring
at birth. Biol Reprod. 2012; 87(4):82. Epub 2012/08/10. biolreprod.112.100636 [pii] doi: 10.1095/
biolreprod.112.100636 PMID: 22875908.
42. Costa RH. FoxM1 dances with mitosis. Nat Cell Biol. 2005; 7(2):108–10. PMID: 15689977
43. Japon MA, Rubinstein M, Low MJ. In situ hybridization analysis of anterior pituitary hormone gene ex-
pression during fetal mouse development. J Histochem Cytochem. 1994; 42(8):1117–25. PMID:
8027530.
44. Wierstra I. The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, tran-
scription factor function, target genes, mouse models, and normal biological roles. Advances in cancer
research. 2013; 118:97–398. doi: 10.1016/B978-0-12-407173-5.00004-2 PMID: 23768511.
45. Zhang N, Wei P, Gong A, Chiu WT, Lee HT, Colman H, et al. FoxM1 promotes beta-catenin nuclear lo-
calization and controls Wnt target-gene expression and glioma tumorigenesis. Cancer Cell. 2011; 20
(4):427–42. doi: 10.1016/j.ccr.2011.08.016 PMID: 22014570; PubMed Central PMCID: PMC3199318.
46. Salisbury TB, Binder AK, Nilson JH. Welcoming beta-catenin to the gonadotropin-releasing hormone
transcriptional network in gonadotropes. Mol Endocrinol. 2008; 22(6):1295–303. doi: 10.1210/me.
2007-0515 PMID: 18218726.
47. Waite E, Lafont C, Carmignac D, Chauvet N, Coutry N, Christian H, et al. Different degrees of somato-
troph ablation compromise pituitary growth hormone cell network structure and other pituitary endocrine
cell types. Endocrinology. 2010; 151(1):234–43. doi: 10.1210/en.2009-0539 PMID: 19887571.
FOXM1 in Pituitary Development
PLOS ONE | DOI:10.1371/journal.pone.0128942 June 15, 2015 16 / 16
